The Immunoglobulins market size is expected to reach $34.52 billion in 2030 at a CAGR of 11.3%, driven by rising healthcare expenditure.
Read More
The Immunoglobulin Fusion Protein market size is expected to reach $87.21 billion in 2030 at a CAGR of 13.6%, driven by autoimmune disorders.
Read More
The Immunocytokines market size is expected to reach $5.44 billion in 2030 at a CAGR of 8.8%, driven by autoimmune disease prevalence.
Read More
The Ileostomy Products market size is expected to reach $2.08 billion in 2030 at a CAGR of 6.8%, driven by gastrointestinal diseases.
Read More
The Ibrutinib market size is expected to reach $64.77 billion in 2030 at a CAGR of 24.0%, driven by blood-related diseases.
Read More
The Hypoprothrombinemia Treatment market size is expected to reach $2.3 billion in 2030 at a CAGR of 8.6%, driven by bleeding disorders.
Read More
The global Hypoparathyroidism market size is expected to reach $1.54 billion in 2030 at a CAGR of 8.2%, driven by thyroid surgeries.
Read More
The Hypolipidemics market size is expected to reach $37.34 billion in 2030 at a CAGR of 3.3%, driven by growing obesity incidences.
Read More
The Hyperuricemia Drugs market size is expected to reach $7.64 billion in 2030 at a CAGR of 8.1%, driven by rising hyperuricemia and gout cases.
Read More
The Hyperphosphatemia Treatment market size is expected to reach $9.52 billion in 2030 at a CAGR of 13.4%, driven by rising chronic disease cases.
Read More